MARKET

NDRA

NDRA

Endra Life Sciences Inc
NASDAQ
4.120
-0.080
-1.90%
After Hours: 4.120 0 0.00% 17:30 02/03 EST
OPEN
4.400
PREV CLOSE
4.200
HIGH
4.400
LOW
4.053
VOLUME
4.64K
TURNOVER
0
52 WEEK HIGH
12.98
52 WEEK LOW
3.159
MARKET CAP
13.01M
P/E (TTM)
-0.8157
1D
5D
1M
3M
1Y
5Y
BRIEF-ENDRA Life Sciences Enters Into Amendment 5 With General Electric
Reuters · 12/19/2022 11:42
Here's Why ENDRA Life Sciences Inc. (NDRA) Could be Great Choice for a Bottom Fisher
After losing some value lately, a hammer chart pattern has been formed for ENDRA Life Sciences Inc. (NDRA), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for ...
Zacks · 12/08/2022 14:55
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 12/05/2022 13:08
BRIEF-Endra Life Sciences Approves A Reverse Stock Split Ratio Of 1-For-20
Reuters · 12/02/2022 21:22
ENDRA Life Sciences Says Following The Special Meeting, Board Approved Reverse Stock Split Ratio Of 1-For-30; Says Co. Intends To Effect Split Prior To Dec. 31, 2022
Benzinga · 12/02/2022 21:16
Endra Life Sciences GAAP EPS of -$0.05
Seekingalpha · 11/14/2022 21:49
BRIEF-ENDRA Life Sciences Reports Third Quarter 2022 Financial Results
Reuters · 11/14/2022 21:28
ENDRA Life Sciences Q3 EPS $(0.05), Inline
Benzinga · 11/14/2022 21:18
More
About NDRA
ENDRA Life Sciences Inc. develops technology for increasing the capabilities of clinical diagnostic ultrasound to broaden patient access to the diagnosis and treatment of various medical conditions in circumstances where other diagnostic technologies are unavailable or impractical. The Company has developed a technology platform, Thermo Acoustic Enhanced Ultrasound (TAEUS), which is intended to enhance the capability of clinical ultrasound technology and support the diagnosis and treatment of various other medical conditions. Its TAEUS technology platform application focuses on quantifying fat in the liver and stage progression of non-alcoholic fatty liver disease (NAFLD), which untreated, can progress to Non-alcoholic Steatohepatitis (NASH), fibrosis, cirrhosis, and liver cancer. The Company's TAEUS platform has various clinical applications, such as tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.

Webull offers kinds of ENDRA Life Sciences Inc stock information, including NASDAQ:NDRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NDRA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NDRA stock methods without spending real money on the virtual paper trading platform.